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Abstract 
Background: Implantation failure is the most important cause of recurrent in vitro fertilization/intra 
cytoplasmic sperm injection (IVF/ICSI) failure. Several reports suggest that intercourse during the 
peritransfer period might improve pregnancy rates. This study is designed to determine whether 
intercourse during the peritransfer period will improve pregnancy and implantation rates in patients 
undergoing IVF or ICSI.  
Materials and Methods: In a randomized control trial study, 390 women with at least five years 
infertility were evaluated. In the study group, 195 patients had intercourse at least once 12 hours after 
embryo transfer. Implantation and clinical pregnancy rates were compared with 195 patients in the 
control group who had no intercourse for the entire assisted reproductive technology (ART) cycle.  
Results: Implantation rate in the study group was 6.5% in comparison with 5.5% for the control 
group. Clinical pregnancy rates were not significantly higher in study patients when compared to 
the control group (14.2% and 11.7% respectively).
Conclusion: The results showed that intercourse during the peritransfer period can not increase 
pregnancy outcome.
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Introduction
Embryo implantation is critically dependent on a 
supportive uterine environment. Uterine receptiv-
ity is the culmination of a cellular and molecular 
transformation mediated locally by paracrine sig-
nals under the governance of ovarian steroid hor-
mones, with cells and cytokines of the immune 
system playing integral roles in this process (1, 2). 
The implantation rates and subsequent pregnancy 
rates in in vitro fertilization (IVF) programs are 
lower than those currently seen in the normal fertile 
population. During IVF treatment regimens, inter-
course is not allowed and artificial insemination is 
normally excluded (3). Semen is now recognized 
as contributing to endometrial preparation for em-
bryo implantation, through the agency of specific 
factors in the seminal plasma fraction of the ejacu-
late. Conventional belief holds that an immune
response to ejaculate antigens should interfere with 
fertilization and establishment of pregnancy. How-
ever, evidence now supports the opposing view 
that insemination acts to activate maternal immune 
mechanisms exerting a positive effect on reproduc-
tive events (4). 
More recently, immunologists have wondered 
whether exposure to proteins in semen helps to 
prepare a woman's reproductive system for con-
ception and pregnancy. Tremellen and his col-
leagues have studied one such protein, transform-
ing growth factor - beta (TGF-β) (5). He proposed 
that immunization with TGF-β through sexual 
intercourse helps the maternal immune system 
learn to tolerate molecular signatures, or antigens, 
in semen by altering the production of inflamma-
tory molecules (cytokines). The cytokines elicited 
by seminal activation also exert embryotrophic 
effects and contribute to optimal preimplantation 
embryo development. 
Previous studies have investigated the role of se-
men exposure in assisted human reproduction. For 
example, in a study by Bellinge, patient insemina-
tion increased pregnancy rates in an IVF program 
(3). Tucker concluded that post operative artifi-
cial insemination improved gamete intra fallopian 
transfer (GIFT) outcome (6). In a study by Tremel-
len, intercourse during assisted human reproduc-
tion improved pregnancy outcomes. (embryos that 
were viable at 6 - 8 weeks) (7). On the other hand, 
Suna reported that the presence of seminal fluid 
in patients undergoing intra uterine insemination 
(IUI)did not improve pregnancy rates (8).
The purpose of our study is to investigate whether 
exposure to semen through vaginal intercourse 
around the time of embryo transfer influences 
pregnancy rates in ART cycles.
 
Materials and Methods
The study was approved by the Ethical Committee 
of Research & Clinical Center for Infertility, Yazd 
University of Medical Science. A written informed 
consent was taken from the patients. Amongst cou-
ples who underwent IVF or ICSI cycles because of 
tubal, male, ovarian, endometriosis, unexplained 
and combined factors, ; 390 patients with a his-
tory of at least 5 years infertility were recruited. 
All patients were down regulated according to the 
long protocol with gonadotropin-releasing hormone 
analogue (GnRH–a) subcutaneously (Buserelin, 
Hoechst, Germany). Subsequently, daily adminis-
tration of human menopausal gonadotropin (HMG, 
Menogon, Ferring, Germany) was added. Once 
an adequate ovarian response had been confirmed 
(presence of at least 2 - 3 follicles ≥ 18 mm in di-
ameter), buserelin and HMG were discontinued and 
10,000 IU human chorionic gonadotropin (HCG, 
Daroupakhsh, Iran) was administered. Transvaginal 
oocyte retrieval was scheduled 36 - 38 hours after 
HCG administration, followed by IVF or ICSI pro-
cedures to achieve oocyte fertilization. All embryos 
were cultured under standard condition for 48 hours 
until they had reached the 2 - 4 cell stage. Patients 
were randomly divided in two groups on the day of 
embryo transfer. Random selection to either group 
was performed by drawing numbered slips of paper 
from a bag which contained equal numbers for each 
method.  The study group patients had intercourse 
at least once during the 12 hours after embryo trans-
fer, whereas the control group patients abstained 
from intercourse for the entire ART cycle. Embryo 
transfer procedures were similar in both groups. All 
embryos were fresh. Luteal phase was supported by 
administration of progesterone (Aburaihan, Iran) in 
oil, 100 mg per day for 14 days. Clinical pregnancy 
was defined as the presence of a gestational sac or 
cardiac activity 3 weeks after embryo transfer. For 
data analysis t test, X2 and Mann- Whitney tests 
were used. A value of p<0.05 was considered statis-
tically significant.
Results
Patients were randomly divided in two groups: 195 
patients in the study group and 195 in the control 
group. The mean age was 29.40 ± 4.4 years for the 
study group and 29.58 ± 4.9 years in the control group 
(p>0.05). The mean duration of infertility was 8.69 ± 
3.8 years (study group) and 8.97 ± 3.9 years (control 
group; p>0.05). There was no significant differences 
in etiology of infertility between both groups (p>0.05). 
The mean number of retrieved oocytes (p>0.05) and 
transferred embryos (p>0.05) were similar in both 
groups. The score of transferred embryos and the en-
dometrial thickness on the day of HCG were similar in 
both groups (p>0.05). Pregnancy results in five study 
group patients were unknown. 
Table 1: Baseline characteristics of the study and control groups 
Groups
p-valueControl group
n= 195
Study group
n = 195Variables
0.70529.58 ± 4.9129.40 ± 4.43Age (years)
NS8.97 ± 3.908.69 ± 3.8Duration of infertility (years)
0.1846.01 ± 3.295.47 ± 2.46Oocyte number
0.9422.49 ± 0.7412.497 ± 0.769Number of transferred embryos
0.63217.39 ± 1.7517.3 ± 1.66Score embryo
0.1319.39 ± 1.039.22 ± 0.83Endometrial thickness on the day of HCG administration
Parameters are presented in Mean ± SD
Table 2: The pregnancy outcome of 385 fresh embryo transfer cycles
                  Groups
p-valueControl group
n = 195
Study group
n = 190Variables
0.486(24/195) 12.3%(28/190) 14.7%Chemical pregnancy (%)
0.476(23/195) 11.7%(27/190) 14.2%Clinical pregnancy (%)
0.500(27/487) 5.5%(32/487) 6.5%Implantation rate (%)
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Chemical pregnancy was 14.7% in the study and 
12.3% in the control group (p>0.05). Clinical 
pregnancy was 14.2% (study group) and 11.7% 
(control group; p>0.05). The implantation rate was 
6.5% in the study group and 5.5% in the control 
group (p=0.5). .Five pregnancies in the study and 
four pregnancies in the control group were twins.
Discussion
Hypothetically, intercourse can impair implantation 
by two mechanisms: the introduction of infection 
and initiation of uterine contractions. Intercourse 
has been linked with ascending uterine infection 
during late pregnancy (9) and subclinical infection 
of the upper reproductive tract is associated with 
poor IVF – embryo transfer outcome (10). Dur-
ing an IVF cycle the uterine cavity is vulnerable 
to intercourse related infection since the cervical 
mucous barrier that prevents ascending infection is 
disrupted by passage of the embryo transfer cath-
eter. On the other hand, uterine myometrial activity 
is increased during intercourse, especially in the 
event of female orgasm (11). These contractions 
may interfere with implantation of the early em-
bryo since high levels of spontaneous uterine ac-
tivity are associated with poor IVF outcome (12). 
However, our study showed that intercourse dur-
ing the peritransfer period of an ART cycle is not 
harmful to early pregnancy outcome. 
On the positive side, intercourse may act to assist 
implantation. In mammals, insemination results in 
the transmission of seminal factors that act (in the 
female reproductive tract,) to promote sperm sur-
vival, to˝ condition˝ the female immune response 
to tolerate the conceptus and to organize molecu-
lar and cellular changes in the endometrium for 
facilitating embryo development and implanta-
tion.  These events are initiated when signaling 
agents, which include TGF-B, other cytokines and 
prostaglandins secreted by seminal vesicles and 
prostate glands, interact with epithelial cells in the 
cervix and uterus to activate cytokine synthesis and 
induce cellular and molecular changes resembling 
a classic inflammatory cascade. The consequences 
are the recruitment and activation of macrophages 
granulocytes and dendritic cells, which have im-
mune regulatory and tissue remodeling roles that 
culminate in improved endometrial receptivity 
to the implanting embryo. Cytokines elicited by 
seminal activity have embryotrophic properties 
and contribute directly to the optimal development 
of the early embryo (13, 14).  In rodents, a lack of 
exposure to seminal plasma results in a decrease in 
the rate of preimplantation embryo cleavage (15) 
and a reduction in the proportion of transferred em-
bryos that successfully implant (16). In humans, 
seminal plasma pessaries have been successfully 
used to enhance implantation rates in women ex-
periencing recurrent miscarriage of unknown ori-
gin (17). 
Bellinge, in a prospective trial, found that deposi-
tion of semen in the high vaginal area results in 
higher implantation rates in IVF cycles (3). In an-
other prospective trial, Fishel et al found no signif-
icant effect of the use of high vaginal insemination 
at the time of oocyte recovery in patients undergo-
ing IVF (18). However, our study demonstrates no 
significant difference in the pregnancy rates with 
or without intercourse. While seminal fluid serves 
as a medium for assisting sperm transport during 
intercourse, and may enhance sperm function and 
survival,  our data does not demonstrate that its 
presence at the time of embryo transfer enhanc-
es fertility potential. Our study suggests that the 
presence of seminal fluid is not essential for the 
establishment of pregnancy when fertilization oc-
curred outside the body. 
In a randomized study by Suna, there is no sig-
nificant difference in the pregnancy rates with or 
without the presence of intravaginal seminal fluid 
in patients undergoing IUI (8). This study shows 
that the presence of intravaginal seminal fluid at 
the time of ovulation does not enhance pregnancy 
establishment when IUI is utilized and extends 
this observation to natural fertilization. Further in-
vestigations are needed to examine the hypothesis 
that seminal fluid affects successful pregnancy 
maintenance. 
Conclusion
In conclusion, implantation is a complex proc-
ess involving ovarian steroids, a multitude of 
paracrine and autocrine factors, and interaction 
between multiple cell types. The mechanisms of 
implantation are not precisely known. Problems 
with implantation and the development of uterine 
receptivity are common. Implantation failure is 
multifactorial in its origin and is a problem that 
is often unrecognized. Any future progress will 
require extensive clinical investigation regarding 
the definition of true defects in uterine receptivity. 
New studies are needed to understand such de-
fects better and to advise better methods to treat 
infertility.  
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